ResMed is a producer and international distributor offering a huge selection of modern CPAP devices and masks for the treatment of obstructive sleep apnea. In its production, it uses the latest available technologies, all in order to create devices that will provide sleep comfort to millions of patients around the world, reducing the negative effects of OSA diseases and thus reducing the costs of health care.
The rich ResMed offer includes:
CPAP devices for continuous pressure in the airways,
anatomical AirFit mask perfectly matching the shape of the face.
For more information, please visit our website www.zdrowysen.info.
AirFit 30 masks
CPAP cameras
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
26.11.Z - Manufacture of electronic components
26.60.Z - Manufacture of irradiation, electromedical and electrotherapeutic equipment
32.50.Z - Manufacture of medical and dental instruments and supplies
33.14.Z - Repair and maintenance of electrical equipment
46.46.Z - Wholesale of pharmaceutical goods
62.03.Z - Computer facilities management activities
63.99.Z - Other information service activities not elsewhere classified
86.90.C - Nurses and midwives activities
86.90.E - Other human health activities notelsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 29,4 | 29,5 | 38,4 | 30,3 |
Liabilities and provisions | 8,8 | 4,7 | 7,1 | 52,7 |
Equity | 6,7 | 7,8 | 8,8 | 13 |
Total assets | 15,4 | 12,4 | 15,9 | 27,9 |
Cash and cash equivalents | 1,4 | 1,9 | 1,9 | -0,2 |
Depreciation | 0,7 | 0,7 | 0,7 | -0 |
Gross profit / loss | 0,6 | 1,2 | 1,4 | 20,4 |
EBITDA | 2 | 2,3 | 3 | 33,4 |
Net profit / loss | 0,6 | 1,1 | 1 | -6,7 |
Operating profit (EBIT) | 1,3 | 1,5 | 2,3 | 49,1 |
Current assets | 14,6 | 11,4 | 14,7 | 28,5 |
% | % | % | p.p. | |
Return on equity (ROE) | 8,5 | 13,9 | 11,5 | -2,4 |
Return on sales (ROS) | 1,9 | 3,7 | 2,6 | -1,1 |
Equity ratio | 43,2 | 62,5 | 55,2 | -7,3 |
EBITDA margin | 6,7 | 7,7 | 7,9 | 0,2 |
Gross profit margin | 1,9 | 4 | 3,7 | -0,3 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 80 | 28 | 43 | 15 |
Current ratio | 2,2 | 4,4 | 3 | -1,4 |
Net debt to EBITDA | -0,7 | -0,8 | -0,6 | 0,2 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.